Vitamin D deficiency is a common health issue; however, the effect of vitamin D deficiency on the survival of T-cell lymphoma is still not clear. We evaluated the impact of serum vitamin D level of patients with peripheral T-cell lymphoma (PTCL) and extranodal natural killer/T-cell lymphoma (ENKTL) on survival outcome. Pretreatment levels of 25-hydroxyvitamin D [25(OH)D] and inflammatory cytokines were measured in serum samples that were archived at diagnosis, and we evaluated their association with survival in newly diagnosed patients with PTCL (n = 137) and ENKTL (n = 114) at a university-based hospital in Korea. An independent cohort from Rui Jin Hospital (Shanghai, China) was used for validation. The median 25(OH)D serum level was 12.0 ng/mL (1.3-60.0 ng/mL), and 40% had less than 10 ng/mL, which was defined as vitamin D deficiency. Median serum 25(OH)D levels were similar between PTCL (11.5 ng/mL) and ENKTL (12.9 ng/mL); however, vitamin D deficiency was associated with inferior survival in ENKTL but not with PTCL. The independent validation cohort (n = 115) also showed a significant association of vitamin D deficiency with poor survival in ENKTL. The 25(OH)D level had an inverse relation with inflammatory cytokines; this association had a negative effect only on survival of ENKTL, and not on PTCL. In conclusion, vitamin D deficiency was associated with inferior survival outcome of patients with ENKTL.
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| INTRODUC TI ON
Vitamin D deficiency is highly prevalent in the general population. Low sun exposure and oral intake are the main reasons for vitamin D deficiency. 1 Beside its main effect on bone metabolism, vitamin D deficiency is a risk factor for cancer development as well as poor treatment outcome. 2 In non-Hodgkin lymphoma (NHL) patients, the prognostic value of vitamin D deficiency has increased interest since a previous cohort study with newly diagnosed NHL patients reported the negative effect of vitamin D deficiency on prognosis. 3 Peripheral T-cell lymphoma and ENKTL were separately analyzed because the current chemotherapy regimens for ENKTL are nonanthracycline-based and L-asparaginase-containing chemotherapies. 9 We also analyzed the correlation of serum levels 
| Serum vitamin D measurement
All archived samples of the discovery cohort were sent to the Hospital laboratory, and the same cutoff value (10 ng/mL) was used.
| Measurement of serum cytokines
We performed multiplexed assays for the measurement of cytokines 
| Statistics
The association of serum vitamin D with categorical variables was analyzed using the χ 2 -test. The Kaplan-Meier method and log-rank test were used to assess the association of vitamin D deficiency and survival. Progression-free survival (PFS) was measured from the date of diagnosis to the date of death from any cause or date of disease progression or relapse, and overall survival (OS) was from the date of diagnosis to the date of death from any cause. Patients without an event or death were censored at the date of the last follow-up visit. THE Cox proportional hazard regression model was used to calculate the hazard ratio of PFS adjusting for prognostic factors, including age, performance status, Ann Arbor stage and serum LDH. All statistical analyses were performed using the software package IBM PASW (version 23.0; SPSS, Chicago, IL, USA) and a 2-sided P-value <.05 was considered significant.
| RE SULTS

| Patients
The discovery cohort consisted of patients who were consecutively diagnosed with PTCL (n = 137) and ENKTL (n = 114) be- respectively. Most PTCL patients (n = 127) were treated with CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) or CHOP-like regimens regardless of stage (Table 1) .
However, stage I/II ENKTL patients were mainly treated with concurrent chemoradiotherapy followed by systemic chemotherapy (n = 60). Remaining stage I/II and III/IV patients received chemotherapy alone (n = 54), and most systemic chemotherapies were based on non-anthracycline and L-asparaginase-containing regimens. [13] [14] [15] Other chemotherapy regimens did not include L-asparaginase such as etoposide, ifosfamide, cisplatin and dexamethasone. 16 The validation cohort consisted of patients who were diagnosed with PTCL (n = 54) and ENKTL (n = 61) be- Vitamin D supplementation was not given to all patients during treatment in the discovery and validation cohort.
| Vitamin D deficiency
The median 35.0 ng/mL), and it was higher than that of the discovery cohort.
Thus, 37 patients (32%) had vitamin D deficiency at diagnosis, whereas 78 patients (68%) had 25(OH)D ≥ 10 ng/mL. However, the distribution of serum 25(OH)D was similar between PTCL (median:
11.5 ng/mL; range: 3.0-30.4 ng/mL) and ENKTL (median: 14.1 ng/ mL; range: 3.0-35.0 ng/mL) patients ( Figure 1D ). Vitamin D deficiency was significantly associated with advanced disease and unfavorable parameters such as serum LDH and poor performance status in the discovery cohort (P < .05; Table 2 ). Accordingly, the response to the first-line treatment was significantly associated with vitamin D deficiency in ENKTL (P < .05; Table 2 ). Although the association between response and vitamin D deficiency was also significant in PTCL, the statistical value was less than that of ENKTL.
| Association of vitamin D deficiency with survival
The estimated median follow-up time of the discovery and vali- Table 3 ).
| Association of vitamin D deficiency with inflammatory cytokines
Sixteen cytokines (IL-6, IL-8, IL-10, IL-18, IL-23, TNFα, MCP-1, MIP-1α, MIP-1β, RANTES, Eotaxin, GROα, IFNα, IFNγ, IP-10 and SDF1α) were examined because the levels of the other cytokines were too low to be analyzed. The mean value of inflammatory cytokines was significantly higher in patients with vitamin D deficiency than in patients without it ( Figure 3A,B) . However, the association of inflammatory cytokines with survival was different between ENKTL and PTCL. Thus, when patients were dichotomized into high and low groups according to the median value, high inflammatory cytokines were significantly associated with survival outcome only in ENKTL,
and not in PTCL ( Figure S3 ).
| D ISCUSS I ON
Vitamin D is one of the most commonly deficient vitamins worldwide and a low level of vitamin D is more common in Asian countries to Western countries. 18, 19 Thus, the National Health and Nutrition Examination Survey (NHNES) in the Korean population that was con- TA B L E 3 Univariate and multivariate analysis for progression-free survival in the discovery cohort In conclusion, our study demonstrated that vitamin D deficiency might be associated with inferior survival outcome of patients with ENKTL but not with PTCL. Further investigations with larger study populations and longer median follow-up than our study are needed to confirm our findings and to determine the effects of vitamin D supplementation in patients with PTCL and ENKTL on survival.
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